Phmurph, I'm suggesting they license Cavatak for one of the cancer types (eg. bladder) at $200m. Imagine the return on separate licences for (how many cancer types are there again?)
But this is just my daydream. No one else has to buy into it!
- Forums
- ASX - By Stock
- VLA
- Broker upgrade
Broker upgrade, page-23
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online